A. Leung

Final results of NKTR-102, a topoisomerase I inhibitor-polymer conjugate, in patients (Pts) with pretreated metastatic breast cancer (MBC) demonstrating significant antitumor activity.

E. Perez, S. Chan, J. Hamm, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Up-Regulation of Retinoic Acid Receptor β Expression in Renal Cancers in Vivo Correlates with Response to 13-cis-Retinoic Acid and Interferon-α-2a

R. Lotan, R. Motzer, M. Mazumdar, 1999 .

Up-Regulation of Retinoic Acid Receptor b Expression in Renal Cancers in Vivo Correlates with Response to 13-cis-Retinoic Acid and Interferon-a-2 a 1

R. Lotan, R. Motzer, M. Mazumdar, 1999 .

Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial.

Sung-Bae Kim, H. Wildiers, P. LoRusso, 2014, The Lancet. Oncology.

SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study.

R. Coffman, E. Schmidt, R. Janssen, 2018, Cancer discovery.

Safety, Clinical Activity, Pharmacokinetics, and Pharmacodynamics from a Phase I Study of PF-06863135, a B-Cell Maturation Antigen (BCMA)-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

A. Jakubowiak, A. Lesokhin, N. Raje, 2019, Blood.

Dose optimization of MK-8628 (OTX015), a small molecule inhibitor of bromodomain and extra-terminal (BET) proteins, in patients (pts) with recurrent glioblastoma (GB).

M. Sanson, O. Chinot, A. Hottinger, 2016 .

A phase I dose escalation study evaluating the safety and tolerability of a novel anti-HER2 antibody-drug conjugate (PF-06804103) in patients with HER2-positive solid tumors.

Yeon-Hee Park, Y. Bang, F. Meric-Bernstam, 2020 .

Randomized multicenter phase II trial comparing two schedules of etirinotecan pegol (NKTR-102) in women with recurrent platinum-resistant/refractory epithelial ovarian cancer.

G. Rustin, I. Vergote, L. Dirix, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The role of NKTR-102 in women with platinum resistant/refractory ovarian cancer and failure on pegylated liposomal doxorubicin (PLD).

G. Rustin, I. Vergote, L. Dirix, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.